Connect
MJA
MJA

Intensive lipid‐lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis

Simon B Dimmitt and Jennifer H Martin
Med J Aust 2019; 211 (6): . || doi: 10.5694/mja2.50324
Published online: 16 September 2019

To the Editor: The efficacy of evidence‐based doses of statins is well established. The poor compliance with high intensity lipid‐lowering pharmacotherapy reported by Brieger and colleagues1 in the CONCORDANCE study has been noted in many studies.2 Compliance is related to several factors, including patients’ perspectives and concerns about quality of life and possible adverse effects3 compared with potential benefits.

  • Simon B Dimmitt1,2
  • Jennifer H Martin2,3

  • 1 University of Western Australia, Perth, WA
  • 2 University of Newcastle, Newcastle, NSW
  • 3 Hunter New England Health, Newcastle, NSW

Correspondence: simon.dimmitt@uwa.edu.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.